Cybercitizen Health® Overview

August 27, 2016

Data and insights to create multichannel patient experiences that drive results

DRG Digital’s Cybercitizen Health® research, insights and advisory services help pharma brands:

  • Understand needs and digital behavior across the patient journey
  • Identify opportunities for pharma to play in remote care and telehealth
  • Plan multichannel and social experiences tailored for specific patient audiences

Coverage for 5 countries and 50+ disease states

 


Our analysts provide brands answers to questions such as:

  • Digital patient journey: How do consumers leverage online resources along the patient journey?
  • Point-of-care dynamics: How do consumers choose their healthcare provider? What activities do they perform online before a doctor’s visit? What is consumer involvement in treatment decisions? 
  • Remote care landscape: What digital communication methods do consumers use to connect with their doctors? What impact does tracking and sharing health measurements with physicians have on consumers’ health management?
  • Telehealth: What is the adoption of telehealth and how are patients using it? What outcomes result from virtual visits and online follow-up materials do patients want?        
  • Social media and health influencers: How does social media impact health decision-making? What type of social content should brands develop, and what type of social health influencers have the most impact on health decisions?
  • Pain points and patient support: What challenges do patients face within the health system? What patient support opportunities should you focus on? 

 

Coverage for some topic areas varies by country


 

  Countries covered:  United States, United Kingdom, France, Germany, Spain, Italy

 

Disease states (US):

Patient, Caregiver & Rx taker segments

  • Acid Reflux
  • Acne
  • ADD/ADHD
  • Age-related Macular Degeneration
  • Allergies
  • Angina
  • Arthritis
  • Osteoarthritis
  •  Rheumatoid arthritis (mild, moderate-severe)
  •  Psoriatic arthritis
  • Parent to child with ankylosing spondylitis
  • Parent to child with juvenile idiopathic arthritis
  • Parent to child with plaque psoriasis
  • Parent to child with Crohn's Disease
  • Arrhythmia
  • Asthma (mild, moderate-severe)
  • Atrial Fibrillation
  • Autism
  • Atopic dermatitis
  • Bipolar Disorder
  • Cancer (diagnosed past 3 years)
  • Breast Cancer
  • Prostate Cancer
  • Skin Cancer
  • Chronic Pain
  • Chronic Bronchitis
  • Chronic kidney disease
  • COPD
 

 

  • Crohn's Disease
  • Cystic Fibrosis
  • Deep Vein Thrombosis
  • Depression
  • Diabetes (T1 & T2)
  • Eczema (mild, moderate-severe)
  • Emphysema
  • Epilepsy
  • Erectile Dysfunction
  • Fibromyalgia
  • Generalized Anxiety Disorder
  • Glaucoma
  • Gout 
  • Growth Hormone Deficiency
  • Heart Attack past 3 years (ages 45+)
  • Heart failure
  • Heart Disease
  • Hepatitis C
  • High Cholesterol
  • HIV or AIDS
  • Insomnia or Sleep Disorder
  • Irritable Bowel Syndrome
  • Low testosterone
  • Migraine
  • Multiple Sclerosis
  • Osteoporosis
  • Organ transplant recipient
  • Overactive Bladder or Urinary Incontinence
  • Overweight or obese (Weight management or obesity for info seekers)
  • Psoriasis (mild, moderate-severe)
  • Stroke
Previous Article
Country-Specific Multichannel Insights
Country-Specific Multichannel Insights

Next Article
ePharma Consumer® Overview
ePharma Consumer® Overview